Tactiva Therapeutics
Chicago, US · 3 known investors
Find your way into Tactiva Therapeutics
Sign up to see every warm intro you have to Tactiva Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Tactiva Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Tactiva Therapeutics develops immuno-oncology treatments using adoptive cell therapy approaches for cancer patients. The company leverages innovative methods in T cell engineering and gene therapy to address metastatic and gynecological cancers.
Founders & leadership
RC
Richard C. KoyaCo-Founder
KO
Kunle OdunsiCo-Founder
JZ
Jay ZhangCEO
Investors · 3
EFung Capitallisted by EFung CapitalShenzhen
How we know: EFung Capital's portfolio page · funding news · Not right? Tell us
VI PartnersreportedAltendorf · $2.2M – $4.5M
How we know: funding news · Not right? Tell us
Funding
SEC filings, press & company announcements$35M disclosed across 1 of 2 rounds · 2018
- $35MSeries ADec 2018 · 2 sourcesSource ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Tactiva Therapeutics do?
- Tactiva Therapeutics develops immuno-oncology treatments using adoptive cell therapy approaches for cancer patients. The company leverages innovative methods in T cell engineering and gene therapy to address metastatic and gynecological cancers.
- Who founded Tactiva Therapeutics?
- Tactiva Therapeutics was founded by Richard C. Koya, Kunle Odunsi.
- Who are Tactiva Therapeutics's investors?
- Tactiva Therapeutics's investors include EFung Capital, Panacea Venture, VI Partners.
- How much funding has Tactiva Therapeutics raised?
- Tactiva Therapeutics has disclosed $35M raised across 1 of its 2 known rounds.
- Where is Tactiva Therapeutics headquartered?
- Tactiva Therapeutics is headquartered in Chicago, US.
